TargED Biopharmaceuticals
Utrecht-based biotechnology company focused on developing improved treatments for thrombotic diseases.
Total raised
€39M
€39,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2022-02
latest 2022-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-24 | Series A | €39M | Andera Partners,Curie Capital,FIRST ,FundPlus,Hadean Ventures,Inkef Capital+2 more | View deal → |
Investors
8Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech